Role of CVVH in Patients With Acute Paraquat Poisoning
NCT01709604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2016-06-14
Summary
Paraquat poisoning is characterized by multiple organ failure and pulmonary fibrosis with respiratory failure. Accumulating evidence suggested that continuous venovenous hemofiltration (CVVH) had a beneficial role in the treatment of multiple organ dysfunction. The investigators hypothesized that CVVH might restore multiple organ function and reduce the high mortality rate of paraquat poisoning. To confirm it, an prospective clinical study would be carried out.
Conditions
- Poisoning by Paraquat With Undetermined Intent
Interventions
- PROCEDURE
-
CVVH
Ultrafiltration at 35ml/h/Kg
- PROCEDURE
-
Standardized therapy regimens
Standardized therapy regimens included the followings: 1. Remove all contaminated clothing 2. Gastric lavage 3. Receive activated charcoal as quickly as possible 4. Hemoperfusion with activated charcoal(160g) 5. Immunosuppression with methylprednisolone 6. Antioxidants (glutathione,1.2 gram iv twice a day) 7. Supportive care
Sponsors & Collaborators
-
Ai Peng
lead OTHER
Principal Investigators
-
Ai Peng, Ph.D., M.D. · Shanghai 10th People's Hospital
Eligibility
- Min Age
- 14 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
Countries
- China
Study Locations
More Related Trials
-
Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis
NCT06122792 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study
NCT01091233 ·Status: WITHDRAWN
-
Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units
NCT01079104 ·Status: TERMINATED ·Phase: NA
-
A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]
NCT02377947 ·Status: COMPLETED
-
The Treatment of Hepatocirrhosis and Portal Hypertension
NCT02778425 ·Status: COMPLETED ·Phase: NA
-
To Study the Efficacy of Intravenous Neostigmine in Resolution of Acute GI Paralysis in Critically Ill Cirrhotics
NCT06462872 ·Status: NOT_YET_RECRUITING
-
RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding
NCT03061604 ·Status: COMPLETED ·Phase: NA
-
The Association Between Albumin Administration and Short-term Rebleeding Risk in Cirrhosis Patients With Acute Variceal Hemorrhage and Stable Hemodynamics
NCT06348004 ·Status: ACTIVE_NOT_RECRUITING
-
Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.
NCT02467348 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)
NCT04050683 ·Status: COMPLETED ·Phase: NA
-
ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver Cirrhosis
NCT01560845 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
NCT01966419 ·Status: COMPLETED ·Phase: PHASE2
-
The Plasma Diafiltration Therapy of Hepatic Failure
NCT03560414 ·Status: UNKNOWN ·Phase: NA
-
High Volume Plasmapheresis for Refractory Hepatic Encephalopathy in Liver Intensive Care Unit.
NCT03115697 ·Status: WITHDRAWN ·Phase: NA
-
Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Gastrointestinal Bleeding and Acute Kidney Injury
NCT07252401 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia
NCT01179607 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Outcome of Thoracocentesis and Pigtail Catheter Drainage in Treatment of Patients With Hepatic Hydrothorax
NCT06319547 ·Status: RECRUITING ·Phase: NA
-
Efficacy & Safety of Pigtail Catheter Drainage Versus Need Based Thoracocentesis for Recurrent Hepatic Hydrothorax.
NCT06007820 ·Status: UNKNOWN ·Phase: NA
-
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
NCT06525623 ·Status: RECRUITING ·Phase: NA
-
Cerebral Microdialysis in Patients With Fulminant Hepatic Failure
NCT00836420 ·Status: COMPLETED
-
The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy
NCT04221672 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Large Volume Paracentesis on Fatigue in Cirrhosis
NCT00603200 ·Status: WITHDRAWN
-
Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic Patients
NCT02017119 ·Status: COMPLETED ·Phase: PHASE2
-
High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure
NCT02718079 ·Status: COMPLETED ·Phase: NA
-
Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension
NCT06970509 ·Status: RECRUITING